JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, Y.
Right arrow Articles by Smith, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, Y.
Right arrow Articles by Smith, F. M.

Vol. 294, Issue 1, 147-154, July 2000

Tachykinin Receptor Subtypes in the Isolated Guinea Pig Heart and Their Role in Mediating Responses to Neurokinin A1

Yingzi Chang, Donald B. Hoover, John C. Hancock and Frank M. Smith2

Department of Pharmacology, College of Medicine, East Tennessee State University, Johnson City, Tennessee (Y.C., D.B.H., J.C.H.); and Department of Anatomy and Neurobiology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada (F.M.S.)

Selective tachykinin agonists were used to identify cardiac and coronary responses mediated by specific tachykinin receptor subtypes in isolated, perfused guinea pig hearts. Receptor desensitization with selective agonists and blockade with selective antagonists were used to determine the role of specific subtypes in generating responses to neurokinin A (NKA). Dose-dependent cardiac and coronary effects were evoked by bolus injections of [Sar9,Met(O2)11]substance P ([Sar9,Met(O2)11]SP), GR64349, and [MePhe7]neurokinin B ([MePhe7]NKB) (selective agonists for NK1, NK2, and NK3 receptors, respectively). Each agonist caused bradycardia, but GR64349 was most effective (34 ± 4% decrease in heart rate with 32 nmol, n = 8). Prominent increases in ventricular contractility and perfusion pressure also occurred with 32 nmol of GR64349 (25 ± 6 and 33 ± 4%, respectively). [Sar9,Met(O2)11]SP was unique in having a high potency for decreasing ventricular contractility and perfusion pressure. Bolus injections of 25 nmol of NKA decreased rate (48 ± 2%, n = 51), increased contractility (26 ± 2%), and had biphasic effects on perfusion pressure (24 ± 1% decrease followed by 9.2 ± 1.4% increase). Desensitization with GR64349 or treatment with the NK2 antagonist SR48968 reduced the bradycardic response to NKA by greater than 75% and eliminated the positive inotropic response. The remaining bradycardia occurred through NK3 receptors. Desensitization with [Sar9,Met(O2)11]SP or NK1 blockade with FK888 eliminated the coronary relaxant action of NKA and enhanced the pressor response. It is concluded that three tachykinin receptor subtypes are present in the guinea pig heart and that each contributes to the overall response evoked by NKA.


1 This study was supported by National Heart, Lung, and Blood Institute Grant HL-54633.

2 F.M.S. was a Research Scholar of the Heart and Stroke Foundation of Canada during part of this study.


0022-3565/00/2941-0147$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
FASEB J.Home page
A. Sexton, M. McDonald, C. Cayla, C. Thiemermann, and A. Ahluwalia
12-Lipoxygenase-derived eicosanoids protect against myocardial ischemia/reperfusion injury via activation of neuronal TRPV1
FASEB J, September 1, 2007; 21(11): 2695 - 2703.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Brownbill, N. J. Bell, R. J. Woods, P. J. Lowry, N. M. Page, and C. P. Sibley
Neurokinin B Is a Paracrine Vasodilator in the Human Fetal Placental Circulation
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2164 - 2170.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.